Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New 5-HT2C receptor modulators under study at GSK

Oct. 27, 2004

Roche claims new 5-HT6 receptor ligands for cognitive disorders, psychosis, etc.

Oct. 27, 2004

Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis

Oct. 27, 2004

Novel MCH receptor antagonists prepared and tested at Schering-Plough

Oct. 27, 2004

Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene

Oct. 27, 2004

New Eg5 kinesin inhibitors developed by AstraZeneca researchers

Oct. 27, 2004

Novel JNK inhibitors and their use reported by Eisai

Oct. 27, 2004

Merck researchers describe new anti-HIV vaccines

Oct. 27, 2004

ARS scientists develop new prostanoid agonists for female infertility, asthma, etc.

Oct. 26, 2004

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...